Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus

Page Menu

Yang Wang

 

 

 

 

 

UMassMed Faculty Page

Inventions:

Title: Broadly Borreliacidal Human Monoclonal Antibodies to OspA and their Uses. UMMS15-03; Patent Pending

Title: Human Antibodies Against Rabies and Uses Thereof. UMMS14-48; Patent Pending. 

  • New neutralizing monoclonal antibodies for rabies RAB2 and RAB3. Can be used together or in combination with RAB1, these antibodies have demonstrated superior performance in the treatment of rabies in comparison to other individually tested antibodies and will cover variety of zootonic strains.

 

Innovation TopicsBiologicsInfectious DiseaseBorreliaBorreliacidal/lymeHuman monoclonalAntibodyPost-exposure prophylacticRabies